Toscano, A., Schoser, B., Saich, R., Berger, K. I., O’Callaghan, L., Haack, K. A., … Kishnani, P. S. (2025). Patient-reported outcomes from the COMET trial comparing avalglucosidase alfa and alglucosidase alfa: a plain language summary. Future Rare Diseases, 5(1). https://doi.org/10.1080/23995270.2025.2498273

Toscano, A., B. Schoser, R. Saich, K. I. Berger, L. O’Callaghan, K. A. Haack, A. Hamed, N. Thibault, and P. S. Kishnani. “Patient-reported outcomes from the COMET trial comparing avalglucosidase alfa and alglucosidase alfa: a plain language summary.” Future Rare Diseases 5, no. 1 (January 1, 2025). https://doi.org/10.1080/23995270.2025.2498273.

Toscano A, Schoser B, Saich R, Berger KI, O’Callaghan L, Haack KA, et al. Patient-reported outcomes from the COMET trial comparing avalglucosidase alfa and alglucosidase alfa: a plain language summary. Future Rare Diseases. 2025 Jan 1;5(1).

Toscano, A., et al. “Patient-reported outcomes from the COMET trial comparing avalglucosidase alfa and alglucosidase alfa: a plain language summary.” Future Rare Diseases, vol. 5, no. 1, Jan. 2025. Scopus, doi:10.1080/23995270.2025.2498273.

Toscano A, Schoser B, Saich R, Berger KI, O’Callaghan L, Haack KA, Hamed A, Thibault N, Kishnani PS. Patient-reported outcomes from the COMET trial comparing avalglucosidase alfa and alglucosidase alfa: a plain language summary. Future Rare Diseases. 2025 Jan 1;5(1).